Gilteritinib
Revision as of 20:12, 14 July 2020 by
UmaMaveli
(
talk
|
contribs
)
(I wrote down the structure of the page)
(
diff
)
← Older revision
|
Latest revision
(
diff
) |
Newer revision →
(
diff
)
Jump to navigation
Jump to search
Editor-In-Chief:
C. Michael Gibson, M.S., M.D.
[1]
Associate Editor(s)-in-Chief:
Overview
Historical Perspective
Drug Classification
Pathophysiology
Causes
Differentiating Gilteritinib From other Drugs
Risks
Natural History, Complications, and Aiding Prognosis
Symptoms and Side Effects
Physical Examination: Before and After
Laboratory Findings
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
OK
Navigation menu
Personal tools
Log in
Request account
Namespaces
Page
Discussion
English
Views
Read
View source
View history
More
Search
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information